SynderBio
Pre-clinicalSynderBio has developed a patented cell separation technology, unlocking the potential of genomic sequencing for cancer diagnostics, single-cell sequencing, and broader life science applications.
Founded
2019
Focus
OncologyImmunology
About
SynderBio has developed a patented cell separation technology, unlocking the potential of genomic sequencing for cancer diagnostics, single-cell sequencing, and broader life science applications.
Company Info
TypePrivate
Founded2019
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile